CASSART PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CASSART PHARMA
Largest movements
- Receivables within one year -€17,604
down €17,604 (-37.7%), from €46,685 to €29,081
of which Trade receivables: -€17,598
- Debts after one year -€61,262
down €61,262 (-5.1%), from €1.2m to €1.1m
of which Financial debts: -€61,262
- Profit (loss) carried forward +€60,977
up €60,977 (+26.7%), from €228,714 to €289,691
- Financial income -€190,000
down €190,000 (-100%), from €190,000 to €0
- Financial charges -€24,513
down €24,513 (-30.1%), from €81,508 to €56,995
- Gross operating margin +€2,068
up €2,068 (+1.5%), from €134,964 to €137,032
- Taxes +€1,827
up €1,827 (+12.6%), from €14,494 to €16,320
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,691,119 | €1,678,847 | -€12,272 | -0.7% |
| Fixed assets | 21/28 | €1,637,874 | €1,637,874 | = | 0.0% |
| Financial fixed assets | 28 | €1,637,874 | €1,637,874 | = | 0.0% |
| Current assets | 29/58 | €53,245 | €40,973 | -€12,272 | -23.0% |
| Amounts receivable within one year | 40/41 | €46,685 | €29,081 | -€17,604 | -37.7% |
| Trade receivables | 40 | €41,170 | €23,572 | -€17,598 | -42.7% |
| Other amounts receivable | 41 | €5,515 | €5,509 | -€6 | -0.1% |
| Cash at bank and in hand | 54/58 | €5,774 | €11,581 | +€5,807 | +101% |
| Deferred charges and accrued income | 490/1 | €786 | €311 | -€475 | -60.5% |
| Total equity and liabilities | 10/49 | €1,691,119 | €1,678,847 | -€12,272 | -0.7% |
| Equity | 10/15 | €231,714 | €292,691 | +€60,977 | +26.3% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €228,714 | €289,691 | +€60,977 | +26.7% |
| Amounts payable | 17/49 | €1,459,405 | €1,386,156 | -€73,249 | -5.0% |
| Amounts payable after more than one year | 17 | €1,205,010 | €1,143,748 | -€61,262 | -5.1% |
| Financial debts | 170/4 | €1,035,010 | €973,748 | -€61,262 | -5.9% |
| Other amounts payable | 178/9 | €170,000 | €170,000 | = | 0.0% |
| Amounts payable within one year | 42/48 | €240,761 | €230,372 | -€10,389 | -4.3% |
| Current portion of amounts payable after more than one year | 42 | €58,760 | €61,262 | +€2,502 | +4.3% |
| Trade debts | 44 | €2,466 | €1,349 | -€1,118 | -45.3% |
| Suppliers | 440/4 | €2,466 | €1,349 | -€1,118 | -45.3% |
| Taxes, remuneration and social security | 45 | €7,369 | €3,882 | -€3,486 | -47.3% |
| Taxes | 450/3 | €5,369 | €3,882 | -€1,486 | -27.7% |
| Remuneration and social security | 454/9 | €2,000 | €0 | -€2,000 | -100% |
| Other amounts payable | 47/48 | €172,166 | €163,879 | -€8,287 | -4.8% |
| Accrued charges and deferred income | 492/3 | €13,634 | €12,036 | -€1,598 | -11.7% |
| Other operating charges | 640/8 | - | €1,074 | +€1,074 | |
| Gross operating margin | 9900 | €134,964 | €137,032 | +€2,068 | +1.5% |
| Operating profit (loss) | 9901 | €134,964 | €135,958 | +€994 | +0.7% |
| Financial income | 75/76B | €190,000 | €0 | -€190,000 | -100% |
| Recurring financial income | 75 | €190,000 | €0 | -€190,000 | -100% |
| Financial charges | 65/66B | €81,508 | €56,995 | -€24,513 | -30.1% |
| Recurring financial charges | 65 | €81,508 | €56,995 | -€24,513 | -30.1% |
| Profit (loss) for the period before taxes | 9903 | €243,456 | €78,963 | -€164,493 | -67.6% |
| Income taxes | 67/77 | €14,494 | €16,320 | +€1,827 | +12.6% |
| Profit (loss) for the period | 9904 | €228,963 | €62,643 | -€166,319 | -72.6% |
| Profit (loss) for the period to be appropriated | 9905 | €228,963 | €62,643 | -€166,319 | -72.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.